Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells

Oncology Reports

Volumn 16, Issue 2, 2006, Pages 313-320

  Gopal, Purva ^a   Rehman, Reiaz U ^a   Chadha, Kanwarjeet S ^a   Qiu, Mengshing ^a   Colella, Rita ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cathepsin B; Cathepsin L; Cysteine proteinase inhibitor; Immunolocalization; Matrigel; Prostate cancer cell lines

Indexed keywords

CATHEPSIN; CATHEPSIN B; CATHEPSIN L; COLLAGEN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; LAMININ; MATRIGEL; PROTEOGLYCAN;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG COMBINATION; ENZYMOLOGY; HUMAN; MALE; PATHOLOGY; PROSTATE TUMOR;

CATHEPSIN B; CATHEPSINS; COLLAGEN; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DRUG COMBINATIONS; HUMANS; LAMININ; MALE; PROSTATIC NEOPLASMS; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 33748560478     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.2.313     Document Type: Article

References (60)

1. Demers M, Couillard J, Belanger and St. Pierre Y: New roles for matrix metalloproteinases in metastasis. Crit Rev Immunol 25: 493-523, 2005. (Pubitemid 44268954)
2. Bellezza T, Aisa MC, Palazzo R, Costanzi E, Mearini E and Minelli A: Extracellular matrix degrading enzymes at the prostasome surface. Prostate Cancer Prostatic Dis 8: 344-348, 2005. (Pubitemid 43078169)
3. Friedrich B, Jung K, Lein M, Turk I, Rudolph B, Hampel G, Schnorr D and Loening SA: Cathepsins B, H, L and cysteine proteinase inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. Eur J Cancer 35: 138-144, 1999. (Pubitemid 29079505)
4. Fernandez PL, Farre X, Nadal A, Fernandez E, Peiro N, Sloane BF, Shi G-P, Chapman HA, Campo E and Cardesa A: Expression of cathepsins B and S in the progression of prostate carcinoma. Int J Cancer 95: 51-55, 2001.
5. Sloane BF and Moin K: Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev 22: 271-286, 2003. (Pubitemid 36561062)
6. Ravanko K, Jarvinen K, Helin J, Kalkkinen N and Holtta E: Cysteine cathepsins are central contributors of invasion of cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts. Cancer Res 64: 8831-8838, 2004. (Pubitemid 39665486)
7. Tao K, Li J, Warner J, MacLeod K, Miller FR and Sahagian GG: Multiple lysosomal trafficking phenotypes in metastatic mouse mammary tumor cell lines. Int J Oncol 19: 1333-1339, 2001.
8. Cavallo-Medved D, Mai J, Dosescu J, Sameni M and Sloane BF: Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells. J Cell Sci 118: 1493-1503, 2005. (Pubitemid 40585129)
9. Buck MR, Karustis DG, Day NA, Honn KV and Sloane BF: Degradation of extracellular matrix protein by human cathepsin B from normal and tumor tissues. Biochem J 282: 273-278, 1992.
10. Ishidoh K and Kominami E: Procathepsin L degrades extracellular matrix protein in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun 217: 624-631, 1995. (Pubitemid 26011756)
11. Mason RW, Johnson DA, Barrett AJ and Chapman HA: Elastinolytic activity of human cathepsin L. Biochem J 233: 925-927, 1986. (Pubitemid 16116171)
12. Maciewicz RA, Etherington DJ, Kos J and Turk V: Collagenolytic cathepsins of rabbit spleen: a kinetic analysis of collagen degradation and inhibition by chicken cystatin. Collagen Relat Res 7: 295-304, 1987.
13. Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta AL and Sloane BF: Degradation of laminin by tumor cathepsin B. Clin Exp Metastasis 7: 461-469, 1989.
14. Guinec N, Dalet-Fumeron V and Pagano M: 'In vitro' study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like, and L. Biol Chem Hoppe-Seyler 374: 1135-1146, 1993.
15. Murphy G, Ward R, Gavrilovic J and Atkinson S: Physiological mechanisms for metalloproteinase activation. Matrix 1 (Suppl 1): 224-230, 1992.
16. Guo M, Mathieu PA, Linebaugh B, Sloane BF and Reiners JJ: Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-β. J Biol Chem 277: 14829-14837, 2002.
17. Ahram M, Sameni M, Qiu R-G, Linebaugh B, Kirn D and Sloane BF: Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix. Exp Cell Res 260: 292-303, 2000.
18. Sameni M, Moin K and Sloane BF: Imaging proteolysis by living human breast cancer cells. Neoplasia 2: 496-504, 2000. (Pubitemid 32098684)
19. Boudreau N and Bissell MJ: Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-646, 1998. (Pubitemid 28477023)
20. Martin KH, Slack JK, Boerner SA, Martin CC and Parsons JT: Integrin connections map: to infinity and beyond. Science 296: 1652-1653, 2002. (Pubitemid 34579156)
21. Bissell MJ, Radisky DC, Rizki A, Weaver VM and Petersen OW: The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70: 537-546, 2002. (Pubitemid 36194318)
22. Lang SH, Sharrard RM, Stark M, Villette JM and Maitland NJ: Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three dimensional Matrigel cultures. Br J Cancer 85: 590-599, 2001. (Pubitemid 32808286)
23. Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG and Pretlow TP: Transplantation of human prostatic carcinoma into nude mice in matrigel. Cancer Res 51: 3814-3817, 1991.
24. Passaniti A, Isaacs JT, Haney JA, Adler SW, Cujdik TJ and Long PV: Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int J Cancer 51: 318-324, 1992.
25. Colella R, Goodwyn E and Gopal P: Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines. Cancer Lett 185: 163-172, 2002.
26. Sinha AA, Gleason DF, Deleon OF, Wilson MJ and Sloane BF: Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat Rec 235: 233-240, 1993. (Pubitemid 23015297)
27. Sinha AA, Quast BJ, Wilson MJ, Reddy PK, Gleason DF and Sloane BF: Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy. Anat Rec 252: 281-289, 1998. (Pubitemid 28440913)
28. Sinha AA, Quast BJ, Korkowski JC, Wilson MJ, Reddy PK, Ewing SL, Sloane BF and Gleason DF: The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score. Anticancer Res 19: 2821-2829, 1999. (Pubitemid 30042558)
29. Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL and Gleason DF: Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Cancer 94: 3141-3149, 2002. (Pubitemid 34670497)
30. Mickey DD, Stone KR, Wunderli H, Mickey G and Paulson DF: Characterization of a human prostate adenocarcinoma cell line (DU145) as a monolayer culture and a solid tumor in athymic mice. In: Models for Prostate Cancer, Murphy GP (ed). Prog Clin Biol Res 37: 67-84, 1980.
31. Kaign ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC3). Investig Urol (Berl) 17: 16-23, 1979. (Pubitemid 9239413)
32. Barrett AJ and Kirsche H: Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 80: 535-561, 1981.
33. Lowry OH, Rosbrough NJ, Farr AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
34. Mason RW, Green GDJ and Barrett AJ: Human liver cathepsin L. Biochem J 226: 233-241, 1985. (Pubitemid 15127929)
35. Troen BR, Ascherman D, Atlas D and Gottesman MM: Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. J Biol Chem 263: 254-261, 1988.
36. Mach L, Mort JS and Glossl J: Maturation of human procathepsin B. J Biol Chem 269: 13030-13035, 1994.
37. Li SC, Chen GF, Chan PSF, Choi HL, Ho S-M and Chan FL: Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids. Prostate 49: 58-71, 2001.
38. Grubb AO: Cystatin C - properties and use as diagnostic marker. Adv Clin Chem 35: 63-99, 2000.
39. Stachowiak K, Rodziewwicz-Motowidlo S, Sosnowska R, Kasprzykowski F, Lankiewicz L, Grugg A and Grzonka Z: Effect of antisense peptide binding on the dimerization of human cystatin C - gel electrophoresis and molecular modeling studies. Acta Biochim Pol 51: 153-160, 2004. (Pubitemid 38608813)
40. Dahl A, Eriksson PS, Davidsson P, Persson AI, Ekman R and Westman-Brinkmalm A: Demonstration of multiple novel glycoforms of the stem cell survival factor CCg. J Neurosci Res 77: 9-14, 2004. (Pubitemid 38850051)
41. Ulbricht B, Henny H, Horstmann H, Spring H, Faigle W and Spiess E: Influence of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) on the location of cathepsin B and cathepsin L in human lung tumor cells. Eur J Cell Biol 74: 294-301, 1997. (Pubitemid 27490221)
42. Andrews NW: Regulated secretion of conventional lysosomes. Trends Cell Biol 10: 316-321, 2000.
43. Nishimura Y, Sameni M and Sloane BF: Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells. Pathol Oncol Res 4: 283-296, 1998. (Pubitemid 29081099)
44. Koblinski JE, Dosescu J, Sameni M, Moin K, Clark K and Sloane BF: Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J Biol Chem 277: 32220-32227, 2002 (Pubitemid 34969037)
45. Klose A, Wilbrand-Hennes A, Zigrino P, Weber E, Krieg T, Mauch C and Hunzelmann N: Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. Int J Cancer 118: 2735-2743, 2006. (Pubitemid 43673351)
46. Linebaugh BE, Sameni M, Day NA, Sloane BF and Keppler D: Exocytosis of active cathepsin B. Eur J Biochem 264: 100-109, 1999.
47. Podgorski I, Linebaugh BE, Sameni M, Jedeszko C, Sunita B, Cher ML and Sloane BF: Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. Neoplasia 7: 207-223, 2005. (Pubitemid 40411633)
48. Witkowski CM, Rabinovitz I, Nagle R, Affinito K-SD and Cress AE: Characterization of integrin subunits, cellular adhesion and tumorigenicity of four human prostate cell lines. J Cancer Res Clin Oncol 119: 637-644, 1993. (Pubitemid 23238145)
49. Sloane BF, Yan S, Podgorski I, Linebaugh BE, Cher ML, Mai J, Cavallo-Medved D, Sameni M, Dosescu J and Moin K: Cathepsin B and tumor proteolysis: Contribution of the tumor microenvironment. Semin Cancer Biol 15: 149-157, 2005. (Pubitemid 40126246)
50. Van Deurs B, Roepstorff K, Hommelgaard AM and Sandvig K: Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 13: 92-100, 2003. (Pubitemid 36135891)
51. Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD and Thompson TC: Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res 61: 3882-3885, 2001. (Pubitemid 32720945)
52. Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittmann MM, Miles BJ, Amato RJ, Kadmon D and Thompson TC: The role of caveolin-1 in androgen insensitive prostate cancer. J Urology 168: 1589-1596, 2002. (Pubitemid 35034195)
53. Cavallo-Medved D, Dosescu J, Linebaugh BE, Sameni M, Rudy D and Sloane BF: Mutant K-ras regulates cathepsin B localization in caveolae of human colorectal carcinoma cells. Neoplasia 5: 1-13, 2003.
54. Hirst SJ, Twort CHC and Lee TH: Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am J Respir Cell Mol Biol 23: 335-344, 2000.
55. Larsen MC, Brake PB, Pollenz RS and Jefcoate CR: Linked expression of Ah receptor, ARNT, CYP1A1, and CYP1B1 in rat mammary epithelia, in vitro, is each substantially elevated by specific extracellular matrix interactions that precede branching morphogenesis. Toxicol Sci 82: 46-61, 2004. (Pubitemid 39485319)
56. Webber MM, Bello D, Klunman HK and Hoffman MP: Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18: 1225-1231, 1997. (Pubitemid 28132514)
57. Ingber DE: Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 70: 547-560, 2002. (Pubitemid 36194319)
58. Nishimura Y, Yoshioka K, Bernard O, Himeno M and Itoh K: LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells. Eur J Cell Biol 83: 369-380, 2004. (Pubitemid 39307174)
59. Sahai E and Marshall CJ: Differing modes of tumor cell invasion have distinct requirements for rho/ROCK signaling and extracellular proteolysis. Nature Cell Biol 5: 711-719, 2003. (Pubitemid 36986778)
60. Buth H, Wolters B, Hartwig B, Meier-Bornheim R, Veith H, Hansen M, Sommerhoff CP, Schaschke N, Machleidt W, Fusenig NE, Boukamp P and Brix K: HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. Eur J Cell Biol 83: 781-795, 2004. (Pubitemid 40123842)